NDC 0121-2232 – Guaifenesin
Guaifenesin 300 mg/15mL · Solution · Oral
Product NDC0121-2232
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- September 1, 2002
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 300 mg/15mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-2232-00 | 10 TRAY in 1 CASE (0121-2232-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-2232-15) | Sep 1, 2002 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 60687-874 Guaifenesin 300 mg/15mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 24689-144 Guaifenesin 400 mg/1 · Tablet · APNAR PHARMA LP
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-857 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-811 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC